Inclusion Criteria:

• * 23 years of age or older.
• * Clinical history of confirmed type 2 diabetes.
• * Evidence of DKD Stages 1-3:
• * Baseline eGFR of 30-60 ml/min/1.73m2 (confirmed 3 months apart with at least one value within 1 year prior to enrollment)
• * Individuals with eGFR ≥60 ml/min/1.73m2 and albuminuria (UACR ≥30mg/g)
• * All patients will have a HbA1c, eGFR, urine albumin and urine creatinine, eGFR, available from within 12 months of enrollment (to be obtained if not clinically available prior).
• * The subject must be able to comprehend and sign an approved informed consent form and other applicable study documents.

Exclusion Criteria:

• * Patients with eGFR \<30 or ≥ 60 ml/min/1.73m2 without albuminuria.
• * Patients with ESRD or on renal recovery treatments at time of enrollment.
• * Patients who are pregnant at the time of enrollment.
• * Patients who are currently hospitalized.
• * Patients who are currently on Enbrel.